Riskpilot← Back to searchSign inGet full accessNeoventor AB
ABActiveOrg 5562814284Mossgatan 16Business and other management consultancy activities · NACE 7020Est. 19860 employees
Revenue 2025
SEK 2,1M
+20288% vs 2024
EBITDA margin
24.0%
+951% vs 2024
Equity ratio
72.9%
Financial strength
Net profit 2025
SEK 443K
+825% vs 2024
| Revenue | SEK 2,1M | +20288% |
| EBITDA | SEK 514K | +951% |
| Net profit | SEK 443K | +825% |
| Total assets | SEK 834K | +316% |
| Equity | SEK 608K | +268% |
| Employees | 0 | — |
Legal name
Neoventor AB
Org number
5562814284
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
12 augusti 1986
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rosén, Karl David
Company purpose
Bolaget skall bedriva konsultverksamhet inom medicinsk teknik samt därmed förenlig verksamhet.
Address
Mossgatan 16
Phone
+46732686612
Email
david.rosen@neoventor.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 201 | 0 | 0 | 11 | 2 141 |
| Staff expenses | — | — | — | — | −1 409 |
| EBITDA | −77 | −22 | −15 | −60 | 514 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −77 | −22 | −15 | −60 | 514 |
| Net financials | — | 0 | 0 | −1 | −0 |
| Profit before tax | −77 | −22 | −15 | −61 | 514 |
| Tax | −0 | — | — | — | −71 |
| Net profit | −77 | −22 | −15 | −61 | 443 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 279 | 254 | 236 | 200 | 834 |
| Equity | 263 | 241 | 226 | 165 | 608 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 15 | 13 | 10 | 35 | 226 |
| Total debt | 15 | 13 | 10 | 35 | 226 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20212025
Equity ratio
72.9%
This company
38.2%
Market median
+91% vs market
20212025
Return on equity
72.8%
This company
18.4%
Market median
+296% vs market
20212025
Net profit margin
20.7%
This company
8.1%
Market median
+156% vs market
20212025
Asset turnover
2.57×
This company
1.12×
Market median
+129% vs market
20212025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2020 | |
| Former (3) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neoventor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Sofia Blad | Chairman | 0 companies |
| Carin Birgitta Rosén | Deputy Board Member | 0 companies |
| Karl David Rosén | Chairman | 0 companies |
| Petra Ulrica Rosén | Board of Directors | 0 companies |
| Hans Edvard Rosén | Board of Directors | 0 companies |
| Karl Gustaf Rosén | Chairman | 0 companies |